INVO Bioscience Inc (INVO)
0.9249
-0.01
(-0.66%)
USD |
NASDAQ |
May 03, 16:00
0.925
0.00 (0.00%)
After-Hours: 07:41
INVO Bioscience Profit Margin (Quarterly): -144.4% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -144.4% |
September 30, 2023 | -128.1% |
June 30, 2023 | -709.2% |
March 31, 2023 | -733.0% |
December 31, 2022 | -994.8% |
September 30, 2022 | -1.08K% |
June 30, 2022 | -1.92K% |
March 31, 2022 | -1.71K% |
December 31, 2021 | -4.64% |
September 30, 2021 | -1.02K% |
June 30, 2021 | -871.7% |
March 31, 2021 | -358.4% |
December 31, 2020 | -1.94K% |
September 30, 2020 | -527.2% |
June 30, 2020 | -537.6% |
March 31, 2020 | -558.6% |
December 31, 2019 | -230.4% |
September 30, 2019 | -234.0% |
June 30, 2019 | -36.67% |
March 31, 2019 | -242.1% |
December 31, 2018 | -497.7% |
September 30, 2018 | -235.8% |
June 30, 2018 | -1.69K% |
March 31, 2018 | -139.0% |
Date | Value |
---|---|
December 31, 2017 | -247.6% |
September 30, 2017 | -218.2% |
June 30, 2017 | -170.5% |
March 31, 2017 | -411.3% |
December 31, 2016 | -2.90K% |
September 30, 2016 | -1.18K% |
June 30, 2016 | -26.73K% |
March 31, 2016 | -1.00K% |
December 31, 2015 | |
September 30, 2015 | -4.90K% |
June 30, 2015 | -80.12K% |
March 31, 2015 | -3.99K% |
December 31, 2011 | -5.10K% |
September 30, 2011 | -770.3% |
June 30, 2011 | -1.41K% |
March 31, 2011 | -601.4% |
December 31, 2010 | -1.34K% |
September 30, 2010 | |
June 30, 2010 | -3.50K% |
March 31, 2010 | |
December 31, 2009 | -2.36K% |
September 30, 2009 | -119.5K% |
June 30, 2009 | -2.64K% |
March 31, 2009 | -1.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.94K%
Minimum
Dec 2020
-4.64%
Maximum
Dec 2021
-723.0%
Average
-558.6%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
Abbott Laboratories | 12.29% |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | -15.31% |
Asensus Surgical Inc | -317.3% |
Catheter Precision Inc | -522.7% |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -70.16% |
Return on Invested Capital | -563.4% |
Gross Profit Margin (Quarterly) | 35.82% |
Operating Margin (Quarterly) | -109.2% |
Return on Net Operating Assets | -84.14% |